Tomlinson, George http://orcid.org/0000-0002-9328-6399
Al-Khafaji, Ali
Conrad, Steven A. http://orcid.org/0000-0002-4014-969X
Factora, Faith N. F. http://orcid.org/0000-0003-4204-9825
Foster, Debra M.
Galphin, Claude
Gunnerson, Kyle J. http://orcid.org/0000-0002-0977-194X
Khan, Sobia
Kohli-Seth, Roopa
McCarthy, Paul
Meena, Nikhil K.
Pearl, Ronald G. http://orcid.org/0000-0002-3998-7637
Rachoin, Jean-Sebastien
Rains, Ronald
Seneff, Michael
Tidswell, Mark
Walker, Paul M.
Kellum, John A. http://orcid.org/0000-0003-1995-2653
Funding for this research was provided by:
Spectral Medical
Article History
Received: 27 July 2023
Accepted: 31 October 2023
First Online: 8 November 2023
Change Date: 3 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13054-023-04791-1
Declarations
:
: For the parent study, Euphrates, all procedures were performed in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975. Prior to randomization, informed consent was obtained from all subjects or their surrogates based on meeting all of the eligibility criteria. The first institutional IRB approval was obtained on 05/18/2010 from Cooper University Hospital IRB (#09-144). The study is registered with clinicaltrials.gov as [NCT01046669].
: Not applicable.
: GT is a paid consultant to Spectral Medical. DMF, and JAK are employees of Spectral Medical. PMW is a member of the Board of Directors of Spectral Medical. AA-K, SAC, FNF, CG, KG, SK, RK-S, PM, NKM, RGP, J-SR, RR, MS and MT are/were investigators in the Tigris and/or EUPHRATES trials and their institutions received funding to conduct the studies.